PATENT CLAIM ANALYSIS

Application Number: 15918100
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "235500"]

Abstract:
The application pertains to methods of treating and/or preventing actinic keratosis, comprising administering a therapeutically effective amount of KX-01, to a subject in need thereof.

Claim (Index 3):
The method of  claim 1 , wherein KX-01 is administered to an affected area of the subject at a dose of about 0.2 mg, about 0.3 mg, about 0.4 mg, about 0.5 mg, about 0.6 mg, about 0.7 mg, about 0.8 mg, about 0.9 mg, about 1 mg, about 1.1 mg, about 1.2 mg, about 1.3 mg, about 1.4 mg, about 1.5 mg, about 1.6 mg, about 1.7 mg, about 1.8 mg, about 1.9 mg, about 2.0 mg, about 2.1 mg, about 2.2 mg, about 2.3 mg, about 2.4 mg, about 2.5 mg, about 2.6 mg, about 2.7 mg, about 2.8 mg, about 2.9 mg, about 3 mg, about 4 mg, or about 5 mg.

Metadata:
- Claim Count in Document: 73.0
- Percentile: 90.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14224063', '12797059', '13179315', '13619983', '14524875']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7577632921809493
- 35 USC 102 Novelty (BERT): 0.5090051214574496
- Combined Prediction Score: 0.7328874751085993
- Mean Citation Score: 202.577106
- Max Citation Score: 218.63602000000003
- Similarity Product: 137.45547928304674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test